Viridian Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-237.73	-129.87	-79.41	-110.72	-41.87	-32.7	-26.52	-17.32	-11.33	-6.64	Upgrade
Depreciation & Amortization	0.57	0.29	0.02	0.24	0.29	0.28	0.31	0.34	0.18	0.14	Upgrade
Share-Based Compensation	67.17	19.77	14.47	3.65	3.97	3.68	2.41	0.2	3.02	4.3	Upgrade
Other Operating Activities	-14.18	15.98	10.35	77.05	1.56	1.9	-4.37	1.98	1.23	-0.02	Upgrade
Operating Cash Flow	-184.17	-93.84	-54.58	-29.78	-36.06	-26.84	-28.17	-14.76	-6.9	-2.21	Upgrade
Capital Expenditures	-0.9	-0.8	-0.26	-0.04	-0.08	-0.45	-0.25	-0.25	-0.12	-0.27	Upgrade
Acquisitions	0	0	0	29.37	0	0	1.28	0	0	0	Upgrade
Change in Investments	-93.35	-114.33	-74.03	-79.81	28.31	-29.46	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-0	-	-	-	-	0.03	-0.01	Upgrade
Investing Cash Flow	-94.25	-115.13	-74.29	-50.48	28.23	-29.91	1.03	-0.25	-0.1	-0.27	Upgrade
Share Issuance / Repurchase	139.58	276.68	109.61	23.76	2.4	44.95	48.35	0.21	12.73	6.64	Upgrade
Debt Issued / Paid	14.49	4.55	0	-8.57	-2.33	0	5.33	-0.34	-0.03	0.75	Upgrade
Other Financing Activities	71.6	41.01	15.67	86.12	-	-3.04	-1.22	16	-	-	Upgrade
Financing Cash Flow	225.67	322.24	125.28	101.31	0.07	41.92	52.47	15.87	12.71	7.4	Upgrade
Net Cash Flow	-52.75	113.28	-3.6	21.05	-7.76	-14.84	25.34	0.87	5.71	4.91	Upgrade
Free Cash Flow	-185.07	-94.64	-54.84	-29.82	-36.14	-27.29	-28.41	-15.01	-7.02	-2.48	Upgrade
Free Cash Flow Margin	-58938.85%	-5340.58%	-1850.83%	-2840.10%	-810.13%	-325.41%	-709.79%	-431.55%	-276.64%	-57.38%	Upgrade
Free Cash Flow Per Share	-4.13	-2.95	-4.60	-8.38	-17.30	-13.83	-22.15	-366.56	-195.22	-247.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).